hNEW YORK, Aug 9 – Pyrosequencing of Uppsala, Sweden said Thursday it had sold a high-throughput PTP genotyping system to Oxagen, a British genomics company.
The deal is the second one between the two companies. Several months ago, Oxagen purchased Pyrosequencing’s PSQ 96 System, a moderate-throughput genotyping system.
The PTP system is an automated system that uses robotics for sample preparation and contains 384-wellplates. The system is able to score up to 100,000 SNPs per day, Pyrosequencing said.
Oxagen is conducting family studies as a way of gaining insight into genetic variation.
"PTP should enable us to scale- up our SNP genotyping capacity based on a proven technology and to reach results at greater speed and lower cost without loss of quality,” Trevor Nicholls, CEO of Oxagen, said in a statement.
Pyrosequencing said it has so far sold more than 100 of systems to customers around the world.